AndreaNataleMD

Clinical Trials

• Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs Start of enrollment: 2007 Mar 01

  Terminated

  Phase 3

• Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD Start of enrollment: 2008 Oct 01

  Completed

  Phase 4

• Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Start of enrollment: 2009 Nov 13

  Completed

  Not Applicable

• Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation Start of enrollment: 2010 Jan 01

  Completed

  Phase 3

• Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia Start of enrollment: 2010 Aug 01

  Terminated

  Phase 3

• Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation Start of enrollment: 2013 Jul 01

  Terminated

  Not Applicable

• Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes Start of enrollment: 2010 Mar 01

  Completed

  Phase 3

• Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation Start of enrollment: 2010 Oct 01

  Completed

  Phase 3

• Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes Start of enrollment: 2010 Sep 01

  Completed

  Phase 4

• Ranolazine Implantable Cardioverter-Defibrillator Trial Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation Start of enrollment: 2011 Jun 01

  Completed

  Phase 3

• Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine Start of enrollment: 2010 Dec 01

  Completed

  Phase 3

• Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF) Start of enrollment: 2012 Jan 01

  Completed

  Phase 3

• Deviating the Esophagus in Atrial Fibrillation Ablation Start of enrollment: 2011 Nov 01

  Terminated

  Not Applicable

• Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators Start of enrollment: 2012 Jun 01

  Terminated

  Phase 4

• Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation Start of enrollment: 2012 Jul 01

  Completed

  Not Applicable

• Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2012 Oct 01

  Completed

  Not Applicable

• Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome? Start of enrollment: 2012 May 01

  Active, not recruiting

• Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF) Start of enrollment: 2012 Dec 01

  Completed

• Cognitive Impairment in Atrial Fibrillation Start of enrollment: 2014 Jul 01

  Recruiting

• Oral Anticoagulation Therapy Pilot Study Start of enrollment: 2013 Apr 17

  Terminated

  Phase 4

• Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2013 Nov 22

  Completed

  Not Applicable

• Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation? Start of enrollment: 2014 May 01

  Completed

• Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation Start of enrollment: 2014 Jul 01

  Completed

• "EASE" Epicardial Access With the EpiAccess System Start of enrollment: 2013 Dec 01

  Completed

  Not Applicable

• Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation Start of enrollment: 2014 Aug 01

  Recruiting

• Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population Start of enrollment: 2016 Jan 01

  Terminated

  Not Applicable

• Half-normal Saline in Atrial Fibrillation Ablation Start of enrollment: 2018 May 02

  Completed

  Not Applicable

• Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation Start of enrollment: 2018 May 16

  Suspended

  Not Applicable

• Transcatheter Leak Closure With Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures Start of enrollment: 2018 Apr 09

  Recruiting

  Not Applicable

• Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU) Start of enrollment: 2018 Sep 04

  Completed

  Phase 4

• DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation Start of enrollment: 2018 Sep 20

  Active, not recruiting

  Not Applicable

• First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3) Start of enrollment: 2019 Sep 24

  Active, not recruiting

  Phase 3

• ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings Start of enrollment: 2020 Mar 27

  Recruiting

• Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function Start of enrollment: 2020 Aug 20

  Recruiting

• Immune Response Following COVID-19 Vaccination Start of enrollment: 2021 Jan 15

  Recruiting

• Join now to see all